Griffin International, Golf Galaxy Announce National Partnership to Benefit Cancer Research Institute
Posted on: Wednesday, 13 June 2007, 12:02 CDT
Griffin International Companies, one of the country's leading manufacturers and suppliers of consumer goods, announced today that it is teaming up with Golf Galaxy, one of the country's largest retail outlets of golfing equipment, apparel and accessories, in a national retail product partnership to support the Cancer Research Institute. For the remainder of 2007, Griffin will donate 5 percent of the net profits from sales of its Kali line of women's golf products, sold exclusively through Golf Galaxy's stores in 29 states, to the Cancer Research Institute in support of the Institute's efforts to develop cancer vaccines and antibody therapies for women's cancers.
"We are very pleased and proud to help support the important activities of the Cancer Research Institute," said Bob Griffin, president and CEO of Griffin International. "This is a great way for Golf Galaxy customers to get some top-notch golf equipment and accessories and to help a very important research endeavor as well. We're especially indebted to Golf Galaxy for making this promotion possible through use of the store and website for in-store support and promotion."
The Kali line of Griffin-developed golf products for women is sold at Golf Galaxy stores throughout the country. Griffin International will also raise awareness of the Cancer Research Institute's science and public education programs by placing the Institute's logo on the products, which include golf head covers, gloves, towels, golf tees, umbrellas and other products for the woman golfer.
"Golf Galaxy is proud to partner with Griffin International on Kali Golf," said Karen Schipke, Golf Galaxy buyer. "Not only will we be providing fresh, new accessories designed specifically for the woman golfer, we will be supporting a very worthy cause in the Cancer Research Institute."
Jill O'Donnell-Tormey, Ph.D., executive director of the Cancer Research Institute, welcomed the opportunity to increase awareness of the Institute's work among Griffin International's customers:
"More than a quarter-million women in the United States will be diagnosed this year with breast, uterine, ovarian, and other women's cancers, and almost 100,000 will die. Through their new partnership with the Cancer Research Institute, Griffin International and Golf Galaxy are helping to fight these diseases and save women's lives."
About Griffin International
Griffin International is based in Minneapolis, Minnesota and is a major manufacturer, supplier and distributor of consumer products for Best Buy, Target, Circuit City, Kohl's, Wal-Mart, Kmart, Sears, Golf Galaxy, Costco, RadioShack, Dick's Sporting Goods, Walgreen's, Transworld and others. In addition, the Griffin International client roster includes Sony, JBL, Hutchinson Whampoa, Starlite, Pentax, Disney, Sonic Impact, Incase, and other companies. Griffin International provides strategic marketing services to these clients and others in the United States, Mexico, Canada and China.
About Golf Galaxy
Golf Galaxy is an innovative, state-of-the-art interactive golf retailer. Designed to contain Everything for the Game, the stores boast comprehensive collections of golf equipment, apparel, accessories, and novelties for all ages and skill levels, as well as a host of interactive features.
About the Cancer Research Institute
The Cancer Research Institute (CRI) is the world's only non-profit, private organization dedicated exclusively to the support and coordination of scientific and clinical efforts that will lead to the immunological treatment, control, and prevention of cancer. Guided by a world-renowned Scientific Advisory Council that includes five Nobel Prize winners and twenty-eight members of the National Academy of Sciences, CRI supports the finest cutting-edge cancer research at top medical centers and universities throughout the world. As the initiator and steward of unprecedented global scientific and clinical collaborations like the Cancer Vaccine Collaborative, a joint program with the international Ludwig Institute for Cancer Research, and the Coordinated Cancer Initiatives, the Cancer Research Institute is ushering in a new era of scientific progress, hastening the discovery of effective cancer vaccines and other immune-based therapies that are providing new hope to cancer patients. The Institute has one of the lowest overhead expense ratios among non-profit organizations, and has consistently earned an A grade or higher for fiscal disclosure and efficiency from the American Institute of Philanthropy and top marks from other charity watchdog organizations. www.cancerresearch.org.
Source: Business Wire
Related Articles
- National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness
- Karmanos Cancer Institute Researchers Provide New Hope for Breast Cancer Treatment
- Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia
- Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
- Karmanos Cancer Institute Researchers Show Phase I Immunotherapy With Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients
- DNA Modification Seen in Colorectal Tumors Helps Predict Outcomes, John Wayne Cancer Institute Researchers Find
- Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
- OHSU Cancer Institute Researcher Identifies Protein Marker for Prostate Cancer Survival
- OHSU Cancer Institute Researcher Finds Drug Combination Helps Halt Prostate Cancer
- Cancer Patient's Patented Ingredient Gets Recognition for Anti Cancer Properties From National Cancer Institute Research
 |
 |
User Comments (0)
RSS Feeds